Provided By StockStory
Last update: May 16, 2025

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. That said, here are three value stocks climbing an uphill battle and some other investments you should look into instead.
Forward P/E Ratio: 14.1x
Formed by the merger of TriQuint and RF Micro Devices, Qorvo (NASDAQ: QRVO) is a designer and manufacturer of RF chips used in almost all smartphones globally, along with a variety of chips used in networking equipment and infrastructure.
Why Are We Out on QRVO?
Qorvo is trading at $78.40 per share, or 14.1x forward P/E. Read our free research report to see why you should think twice about including QRVO in your portfolio.
Forward P/E Ratio: 11.1x
Best known for its fruit jams and spreads, J.M Smucker (NYSE:SJM) is a packaged foods company whose products span from peanut butter and coffee to pet food.
Why Does SJM Worry Us?
J. M. Smucker’s stock price of $112.79 implies a valuation ratio of 11.1x forward P/E. If you’re considering SJM for your portfolio, see our FREE research report to learn more.
Forward P/E Ratio: 9.6x
With a network of approximately 2,620 affiliated physicians caring for some of the most vulnerable patients, Pediatrix Medical Group (NYSE:MD) provides specialized physician services focused on neonatal, maternal-fetal, pediatric cardiology and other pediatric subspecialty care across 37 states.
Why Do We Avoid MD?
At $14.88 per share, Pediatrix Medical Group trades at 9.6x forward P/E. Check out our free in-depth research report to learn more about why MD doesn’t pass our bar.
Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free.
85.92
-0.65 (-0.75%)
100.39
+0.69 (+0.69%)
22.56
+0.24 (+1.08%)
Find more stocks in the Stock Screener


